Advanced search
1 file | 2.99 MB Add to list

Chemoselective peptide backbone diversification and bioorthogonal ligation by ruthenium-catalyzed C-H activation/annulation

(2021) ADVANCED SYNTHESIS & CATALYSIS. 363(13). p.3297-3304
Author
Organization
Abstract
The field of peptide derivatization by metal-catalyzed C-H activation has been mostly directed to modify the side chains, but poor attention has been given to the peptide backbone. Here we report a ruthenium-catalyzed C-H activation/annulation process that can chemoselectively modify the peptide backbone producing functionalized isoquinolone scaffolds with high regioselectivity in a rapid and step-economical manner. This strategy is characterized by racemization-free conditions and the production of fluorescent peptides, and peptide conjugates to drugs, natural products and other peptide fragments, providing a chemical approach for the construction of novel peptide-pharmacophore conjugates. Mechanistic studies suggest that amide bonds of peptide backbone act as the bidentate directing group to promote the C-H activation/annulation process. This report provides an unprecedented example of peptide backbone diversification and bioorthogonal ligation exploiting the power of ruthenium-catalyzed C-H activation.
Keywords
Peptides, C-H Activation, Metal catalysis, Ruthenium, Annulation, AMINO-ACIDS, FUNCTIONALIZATION, ACTIVATION, MACROCYCLIZATION, CYCLIZATION, ALKYLATION, ANNULATION, STRATEGIES, LIGAND

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 2.99 MB

Citation

Please use this url to cite or link to this publication:

MLA
Song, Liangliang, et al. “Chemoselective Peptide Backbone Diversification and Bioorthogonal Ligation by Ruthenium-Catalyzed C-H Activation/Annulation.” ADVANCED SYNTHESIS & CATALYSIS, vol. 363, no. 13, 2021, pp. 3297–304, doi:10.1002/adsc.202100323.
APA
Song, L., Ojeda-Carralero, G. M., Parmar, D., Gonzalez-Martinez, D. A., Van Meervelt, L., Van der Eycken, J., … Van der Eycken, E. V. (2021). Chemoselective peptide backbone diversification and bioorthogonal ligation by ruthenium-catalyzed C-H activation/annulation. ADVANCED SYNTHESIS & CATALYSIS, 363(13), 3297–3304. https://doi.org/10.1002/adsc.202100323
Chicago author-date
Song, Liangliang, Gerardo M. Ojeda-Carralero, Divyaakshar Parmar, David A. Gonzalez-Martinez, Luc Van Meervelt, Johan Van der Eycken, Jan Goeman, Daniel G. Rivera, and Erik V. Van der Eycken. 2021. “Chemoselective Peptide Backbone Diversification and Bioorthogonal Ligation by Ruthenium-Catalyzed C-H Activation/Annulation.” ADVANCED SYNTHESIS & CATALYSIS 363 (13): 3297–3304. https://doi.org/10.1002/adsc.202100323.
Chicago author-date (all authors)
Song, Liangliang, Gerardo M. Ojeda-Carralero, Divyaakshar Parmar, David A. Gonzalez-Martinez, Luc Van Meervelt, Johan Van der Eycken, Jan Goeman, Daniel G. Rivera, and Erik V. Van der Eycken. 2021. “Chemoselective Peptide Backbone Diversification and Bioorthogonal Ligation by Ruthenium-Catalyzed C-H Activation/Annulation.” ADVANCED SYNTHESIS & CATALYSIS 363 (13): 3297–3304. doi:10.1002/adsc.202100323.
Vancouver
1.
Song L, Ojeda-Carralero GM, Parmar D, Gonzalez-Martinez DA, Van Meervelt L, Van der Eycken J, et al. Chemoselective peptide backbone diversification and bioorthogonal ligation by ruthenium-catalyzed C-H activation/annulation. ADVANCED SYNTHESIS & CATALYSIS. 2021;363(13):3297–304.
IEEE
[1]
L. Song et al., “Chemoselective peptide backbone diversification and bioorthogonal ligation by ruthenium-catalyzed C-H activation/annulation,” ADVANCED SYNTHESIS & CATALYSIS, vol. 363, no. 13, pp. 3297–3304, 2021.
@article{8721577,
  abstract     = {{The field of peptide derivatization by metal-catalyzed C-H activation has been mostly directed to modify the side chains, but poor attention has been given to the peptide backbone. Here we report a ruthenium-catalyzed C-H activation/annulation process that can chemoselectively modify the peptide backbone producing functionalized isoquinolone scaffolds with high regioselectivity in a rapid and step-economical manner. This strategy is characterized by racemization-free conditions and the production of fluorescent peptides, and peptide conjugates to drugs, natural products and other peptide fragments, providing a chemical approach for the construction of novel peptide-pharmacophore conjugates. Mechanistic studies suggest that amide bonds of peptide backbone act as the bidentate directing group to promote the C-H activation/annulation process. This report provides an unprecedented example of peptide backbone diversification and bioorthogonal ligation exploiting the power of ruthenium-catalyzed C-H activation.}},
  author       = {{Song, Liangliang and Ojeda-Carralero, Gerardo M. and Parmar, Divyaakshar and Gonzalez-Martinez, David A. and Van Meervelt, Luc and Van der Eycken, Johan and Goeman, Jan and Rivera, Daniel G. and Van der Eycken, Erik V.}},
  issn         = {{1615-4150}},
  journal      = {{ADVANCED SYNTHESIS & CATALYSIS}},
  keywords     = {{Peptides,C-H Activation,Metal catalysis,Ruthenium,Annulation,AMINO-ACIDS,FUNCTIONALIZATION,ACTIVATION,MACROCYCLIZATION,CYCLIZATION,ALKYLATION,ANNULATION,STRATEGIES,LIGAND}},
  language     = {{eng}},
  number       = {{13}},
  pages        = {{3297--3304}},
  title        = {{Chemoselective peptide backbone diversification and bioorthogonal ligation by ruthenium-catalyzed C-H activation/annulation}},
  url          = {{http://doi.org/10.1002/adsc.202100323}},
  volume       = {{363}},
  year         = {{2021}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: